| 1 |
Ryll M, Lei Y, Thomas MN, Li M, Renz B, Wirth U, Kühn F, Bazhin A, Werner J, Anders HJ, Andrassy J. The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention. Transpl Immunol 2023;77:101782. [PMID: 36608832 DOI: 10.1016/j.trim.2022.101782] [Reference Citation Analysis]
|
| 2 |
Nakazawa M, Tochinai R, Fujii W, Yonezawa T, Momoi Y, Maeda S. Protective role of protease-activated receptor-2 in anaphylaxis model mice.. [DOI: 10.1101/2023.03.22.533779] [Reference Citation Analysis]
|
| 3 |
Vander Does A, Ju T, Mohsin N, Chopra D, Yosipovitch G. How to get rid of itching. Pharmacol Ther 2023;243:108355. [PMID: 36739914 DOI: 10.1016/j.pharmthera.2023.108355] [Reference Citation Analysis]
|
| 4 |
Zhang X, Lee MD, Buckley C, Hollenberg MD, Wilson C, McCarron JG. Endothelial PAR2 activation evokes resistance artery relaxation. J Cell Physiol 2023. [PMID: 36791026 DOI: 10.1002/jcp.30973] [Reference Citation Analysis]
|
| 5 |
Park HJ, Kataru RP, Shin J, Garc A Nores GD, Encarnacion EM, Klang MG, Riedel E, Coriddi M, Dayan JH, Mehrara BJ. Keratinocytes coordinate inflammatory responses and regulate development of secondary lymphedema. bioRxiv 2023:2023. [PMID: 36711669 DOI: 10.1101/2023.01.20.524936] [Reference Citation Analysis]
|
| 6 |
Huang Y, Zhao X, Zhang Q, Yang X, Hou G, Peng C, Jia M, Zhou L, Yamamoto T, Zheng J. Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation. Expert Opin Ther Targets 2023;27:55-69. [PMID: 36738160 DOI: 10.1080/14728222.2023.2177534] [Reference Citation Analysis]
|
| 7 |
Li J, Huang J, Zhang R, Lin Y, Chen Q, Gan X. Pretreatment with propofol restores intestinal epithelial cells integrity disrupted by mast cell degranulation in vitro. Physiol Res 2022;71:849-858. [DOI: 10.33549/physiolres.934933] [Reference Citation Analysis]
|
| 8 |
Fleischer MI, Röhrig N, Raker VK, Springer J, Becker D, Ritz S, Bros M, Stege H, Haist M, Grabbe S, Haub J, Becker C, Reyda S, Disse J, Schmidt T, Mahnke K, Weiler H, Ruf W, Steinbrink K. Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation. J Thromb Haemost 2022;20:2823-36. [PMID: 36161697 DOI: 10.1111/jth.15894] [Reference Citation Analysis]
|
| 9 |
Reches G, Blondheim Shraga NR, Carrette F, Malka A, Saleev N, Gubbay Y, Ertracht O, Haviv I, Bradley LM, Levine F, Piran R. Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries. Inflamm Regen 2022;42:52. [PMID: 36447218 DOI: 10.1186/s41232-022-00238-2] [Reference Citation Analysis]
|
| 10 |
Calls A, Torres-Espin A, Tormo M, Martínez-Escardó L, Bonet N, Casals F, Navarro X, Yuste VJ, Udina E, Bruna J. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice. Ann Clin Transl Neurol 2022;9:1985-98. [PMID: 36369764 DOI: 10.1002/acn3.51691] [Reference Citation Analysis]
|
| 11 |
Chu TY, Zheng-Gérard C, Huang KY, Chang YC, Chen YW, I KY, Lo YL, Chiang NY, Chen HY, Stacey M, Gordon S, Tseng WY, Sun CY, Wu YM, Pan YS, Huang CH, Lin CY, Chen TC, El Omari K, Antonelou M, Henderson SR, Salama A, Seiradake E, Lin HH. GPR97 triggers inflammatory processes in human neutrophils via a macromolecular complex upstream of PAR2 activation. Nat Commun 2022;13:6385. [PMID: 36302784 DOI: 10.1038/s41467-022-34083-1] [Reference Citation Analysis]
|
| 12 |
Globisch MA, Onyeogaziri FC, Smith RO, Arce M, Magnusson PU. Dysregulated Hemostasis and Immunothrombosis in Cerebral Cavernous Malformations. IJMS 2022;23:12575. [DOI: 10.3390/ijms232012575] [Reference Citation Analysis]
|
| 13 |
D’alessandro E, Winters J, van Nieuwenhoven FA, Schotten U, Verheule S. The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis. Cells 2022;11:2963. [DOI: 10.3390/cells11192963] [Reference Citation Analysis]
|
| 14 |
Beckmann L, Mäder J, Voigtländer M, Klingler F, Schulenkorf A, Lehr C, Regenhardt J, Bokemeyer C, Ruf W, Rolling C, Langer F. Inhibition of protein disulfide isomerase with PACMA-31 regulates monocyte tissue factor through transcriptional and posttranscriptional mechanisms. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.09.024] [Reference Citation Analysis]
|
| 15 |
Ramos-llorca A, Scarpellini C, Augustyns K. Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction. IJMS 2022;23:9795. [DOI: 10.3390/ijms23179795] [Reference Citation Analysis]
|
| 16 |
Gandhi VD, Shrestha Palikhe N, Vliagoftis H. Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity. Front Med 2022;9. [DOI: 10.3389/fmed.2022.954990] [Reference Citation Analysis]
|
| 17 |
Weng H, Pham QTT, Chang C, Tsai T. Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects. Pharmaceuticals 2022;15:892. [DOI: 10.3390/ph15070892] [Reference Citation Analysis]
|
| 18 |
Hellman L, Akula S, Fu Z, Wernersson S. Mast Cell and Basophil Granule Proteases - In Vivo Targets and Function. Front Immunol 2022;13:918305. [DOI: 10.3389/fimmu.2022.918305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Ha S, Yang Y, Kim BM, Kim J, Son M, Kim D, Yu HS, Im DS, Chung HY, Chung KW. Activation of PAR2 promotes high-fat diet-induced renal injury by inducing oxidative stress and inflammation. Biochim Biophys Acta Mol Basis Dis 2022;1868:166474. [PMID: 35772632 DOI: 10.1016/j.bbadis.2022.166474] [Reference Citation Analysis]
|
| 20 |
Liu C, Jiang S, Xie H, Jia H, Li R, Zhang K, Wang N, Lin P, Yu X. Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway. Med Oncol 2022;39. [DOI: 10.1007/s12032-022-01689-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Palumbo JS. Crosstalk between hemostasis and immunity in cancer pathogenesis. Thrombosis Research 2022;213:S3-7. [DOI: 10.1016/j.thromres.2021.12.013] [Reference Citation Analysis]
|
| 22 |
Zhang W, Zhu Q. Punicalagin suppresses inflammation in ventilator-induced lung injury through protease-activated receptor-2 inhibition-induced inhibition of NLR family pyrin domain containing-3 inflammasome activation. Chem Biol Drug Des 2022. [PMID: 35434894 DOI: 10.1111/cbdd.14059] [Reference Citation Analysis]
|
| 23 |
Sohaim S, Mohammed S, Amin E, Ali HM, Abdelbakky M. Date palm seed extract and herbal mixture mitigate gentamicin-induced renal injury in mice: Role of Protease-activated receptors (PARs) and Retinoid X receptor alpha (RXR-α). J Herbmed Pharmacol 2022;11:286-95. [DOI: 10.34172/jhp.2022.34] [Reference Citation Analysis]
|
| 24 |
Ha S, Chung KW, Lee J, Chung HY, Moon HR. Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process. Arch Pharm Res 2022. [PMID: 35334088 DOI: 10.1007/s12272-022-01375-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Fang L, Ohashi K, Ogawa H, Otaka N, Kawanishi H, Takikawa T, Ozaki Y, Takahara K, Tatsumi M, Takefuji M, Murohara T, Ouchi N. Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial-mesenchymal transition and inflammatory response. Physiol Rep 2022;10:e15218. [PMID: 35262272 DOI: 10.14814/phy2.15218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 26 |
Kim Y, Lee Y, Heo G, Jeong S, Park S, Yoo J, Jung Y, Im E. Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy. Cells 2022;11:878. [DOI: 10.3390/cells11050878] [Reference Citation Analysis]
|
| 27 |
Bradshaw RA, Lundblad RL. Protein Synthesis/Degradation: Protein Degradation – Protease Classes – Kallikrein and Kallikrein-Related Peptidases. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00051-1] [Reference Citation Analysis]
|
| 28 |
Xu J, Cao K, Liu X, Zhao L, Feng Z, Liu J. Punicalagin Regulates Signaling Pathways in Inflammation-Associated Chronic Diseases. Antioxidants (Basel) 2021;11:29. [PMID: 35052533 DOI: 10.3390/antiox11010029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Ma Y, Zhang Y, Qiu C, He C, He T, Shi S, Liu Z. Rivaroxaban Suppresses Atherosclerosis by Inhibiting FXa-Induced Macrophage M1 Polarization-Mediated Phenotypic Conversion of Vascular Smooth Muscle Cells. Front Cardiovasc Med 2021;8:739212. [PMID: 34869643 DOI: 10.3389/fcvm.2021.739212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 30 |
Mazur P, Kopytek M, Ząbczyk M, Undas A, Natorska J. Towards Personalized Therapy of Aortic Stenosis. J Pers Med 2021;11:1292. [PMID: 34945764 DOI: 10.3390/jpm11121292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 31 |
Kopytek M, Mazur P, Ząbczyk M, Undas A, Natorska J. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification. Diabetologia 2021;64:2562-74. [PMID: 34494136 DOI: 10.1007/s00125-021-05545-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 32 |
Sukiman MZ, Chai MH, Sharifuddin NS, Shamin A, Ariffin SMZ, Ghazali MF. Protease-activated receptor 2 expression in the mammary gland tissues in correlation with mastitis severity in goats. IOP Conf Ser : Earth Environ Sci 2021;888:012033. [DOI: 10.1088/1755-1315/888/1/012033] [Reference Citation Analysis]
|
| 33 |
Kim JM, Park J, Noh EM, Song HK, Kang SY, Jung SH, Kim JS, Youn HJ, Lee YR. Downregulation of matriptase suppresses the PAR‑2/PLCγ2/PKC‑mediated invasion and migration abilities of MCF‑7 breast cancer cells. Oncol Rep 2021;46:247. [PMID: 34608498 DOI: 10.3892/or.2021.8198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Kim YS, Go G, Yun CW, Yea JH, Yoon S, Han SY, Lee G, Lee MY, Lee SH. Topical Administration of Melatonin-Loaded Extracellular Vesicle-Mimetic Nanovesicles Improves 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis. Biomolecules 2021;11:1450. [PMID: 34680082 DOI: 10.3390/biom11101450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Stepchenko AG, Portseva TN, Glukhov IA, Kotnova AP, Lyanova BM, Georgieva SG, Pankratova EV. Primate-specific stress-induced transcription factor POU2F1Z protects human neuronal cells from stress. Sci Rep 2021;11:18808. [PMID: 34552146 DOI: 10.1038/s41598-021-98323-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Beckmann L, Rolling CC, Voigtländer M, Mäder J, Klingler F, Schulenkorf A, Lehr C, Bokemeyer C, Ruf W, Langer F. Bacitracin and Rutin Regulate Tissue Factor Production in Inflammatory Monocytes and Acute Myeloid Leukemia Blasts. Cancers (Basel) 2021;13:3941. [PMID: 34439096 DOI: 10.3390/cancers13163941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Yamakage S, Oe Y, Sato E, Okamoto K, Sekimoto A, Kumakura S, Sato H, Yoshida M, Nagasawa T, Miyazaki M, Ito S, Mackman N, Takahashi N. Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet. Sci Rep 2021;11:12159. [PMID: 34108522 DOI: 10.1038/s41598-021-91586-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 38 |
Bang E, Kim DH, Chung HY. Protease-activated receptor 2 induces ROS-mediated inflammation through Akt-mediated NF-κB and FoxO6 modulation during skin photoaging. Redox Biol 2021;44:102022. [PMID: 34082382 DOI: 10.1016/j.redox.2021.102022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 39 |
Saffarzadeh M, Grunz K, Nguyen TS, Lee YK, Kitano M, Danckwardt S, Rodrigues CDS, Weiler H, Reyda S, Ruf W. Macrophage protease-activated receptor 2 regulates fetal liver erythropoiesis in mice. Blood Adv 2020;4:5810-24. [PMID: 33232477 DOI: 10.1182/bloodadvances.2020003299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 40 |
Alaaeddine RA, AlZaim I, Hammoud SH, Arakji A, Eid AH, Abd-Elrahman KS, El-Yazbi AF. The pleiotropic effects of antithrombotic drugs in the metabolic-cardiovascular-neurodegenerative disease continuum: impact beyond reduced clotting. Clin Sci (Lond) 2021;135:1015-51. [PMID: 33881143 DOI: 10.1042/CS20201445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 41 |
Duarte FCK, Hurtig M, Clark A, Brown S, Simpson J, Srbely J. Experimentally induced spine osteoarthritis in rats leads to neurogenic inflammation within neurosegmentally linked myotomes. Exp Gerontol 2021;149:111311. [PMID: 33744392 DOI: 10.1016/j.exger.2021.111311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Kim DH, Kim YR, Bang E, Ha S, Noh SG, Kim BM, Jeong SH, Jung HJ, Lee JY, Chung HY. Mechanism of Lipid Accumulation through PAR2 Signaling in Diabetic Male Mice. Endocrinol Metab (Seoul) 2021;36:171-84. [PMID: 33677938 DOI: 10.3803/EnM.2020.850] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
McMahon DB, Carey RM, Kohanski MA, Adappa ND, Palmer JN, Lee RJ. PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 2021;320:L845-79. [PMID: 33655758 DOI: 10.1152/ajplung.00411.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 44 |
Fu Y, Liu L, Li X, Chen H, Wang Z, Yang W, Zhang H, Zhang H. Peptide modified manganese-doped iron oxide nanoparticles as a sensitive fluorescence nanosensor for non-invasive detection of trypsin activity in vitro and in vivo. RSC Adv 2021;11:2213-20. [PMID: 35424166 DOI: 10.1039/d0ra08171j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 45 |
Ewees MGE, Abdel-Bakky MS, Bayoumi AMA, Abo-Saif AA, Altowayan WM, Alharbi KS, Messiha BAS. Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway. J Adv Res 2021;31:127-36. [PMID: 34194837 DOI: 10.1016/j.jare.2020.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 46 |
Kennedy AJ, Sundström L, Geschwindner S, Poon EKY, Jiang Y, Chen R, Cooke R, Johnstone S, Madin A, Lim J, Liu Q, Lohman RJ, Nordqvist A, Fridén-Saxin M, Yang W, Brown DG, Fairlie DP, Dekker N. Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition. Commun Biol 2020;3:782. [PMID: 33335291 DOI: 10.1038/s42003-020-01504-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 47 |
Wang Y, Yu Z, Xiao W, Lu S, Zhang J. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery. Drug Discov Today 2021;26:690-703. [PMID: 33301977 DOI: 10.1016/j.drudis.2020.12.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 48 |
Friebel J, Weithauser A, Witkowski M, Rauch BH, Savvatis K, Dörner A, Tabaraie T, Kasner M, Moos V, Bösel D, Gotthardt M, Radke MH, Wegner M, Bobbert P, Lassner D, Tschöpe C, Schutheiss HP, Felix SB, Landmesser U, Rauch U. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction. Eur Heart J 2019;40:3318-32. [PMID: 31004144 DOI: 10.1093/eurheartj/ehz117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 49 |
Kaji K, Kaji N, Hori M, Sakai K, Yonezawa T, Maeda S. Protease-Activated Receptor-2 Is Associated With Adverse Outcomes in Canine Mammary Carcinoma. Vet Pathol 2021;58:53-62. [PMID: 33054598 DOI: 10.1177/0300985820963087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Joossen C, Baán A, Moreno-Cinos C, Joossens J, Cools N, Lanckacker E, Moons L, Lemmens K, Lambeir AM, Fransen E, Delputte P, Caljon G, Van Der Veken P, Maes L, De Meester I, Kiekens F, Augustyns K, Cos P. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation. Sci Rep 2020;10:17268. [PMID: 33057006 DOI: 10.1038/s41598-020-74159-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 51 |
Tomuschat C, O'Donnell AM, Coyle D, Puri P. Increased protease activated receptors in the colon of patients with Hirschsprung's disease. J Pediatr Surg 2020;55:1488-94. [PMID: 31859043 DOI: 10.1016/j.jpedsurg.2019.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 52 |
Majewski MW, Gandhi DM, Holyst T, Wang Z, Hernandez I, Rosas R Jr, Zhu J, Weiler H, Dockendorff C. Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin αVβ3 and PAR2. RSC Med Chem 2020;11:940-9. [PMID: 33479689 DOI: 10.1039/d0md00098a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 53 |
Seo Y, Mun CH, Park SH, Jeon D, Kim SJ, Yoon T, Ko E, Jo S, Park YB, Namkung W, Lee SW. Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2. Int J Mol Sci 2020;21:E4975. [PMID: 32674502 DOI: 10.3390/ijms21144975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 54 |
de Almeida AD, Silva IS, Fernandes-Braga W, LimaFilho ACM, Florentino ROM, Barra A, de Oliveira Andrade L, Leite MF, Cassali GD, Klein A. A role for mast cells and mast cell tryptase in driving neutrophil recruitment in LPS-induced lung inflammation via protease-activated receptor 2 in mice. Inflamm Res 2020;69:1059-70. [PMID: 32632517 DOI: 10.1007/s00011-020-01376-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 55 |
Yamakage S, Oe Y, Sekimoto A, Obata H, Yasuta M, Sato E, Kumakura S, Sato H, Sugawara J, Ito S, Takahashi N. Protease-activated receptor 2 contributes to placental development and fetal growth in mice. Thromb Res 2020;193:173-9. [PMID: 32717642 DOI: 10.1016/j.thromres.2020.06.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 56 |
Mella C, Figueroa CD, Otth C, Ehrenfeld P. Involvement of Kallikrein-Related Peptidases in Nervous System Disorders. Front Cell Neurosci 2020;14:166. [PMID: 32655372 DOI: 10.3389/fncel.2020.00166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 57 |
Di Paolo CT, Diamandis EP, Prassas I. The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets. Crit Rev Clin Lab Sci 2021;58:1-16. [PMID: 32568598 DOI: 10.1080/10408363.2020.1775171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 58 |
Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD, Vagner J, Boitano S, Akopian AN, Dussor G, Price TJ. The cellular basis of protease-activated receptor 2-evoked mechanical and affective pain. JCI Insight 2020;5:137393. [PMID: 32352932 DOI: 10.1172/jci.insight.137393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 59 |
Boo HJ, Park SJ, Noh M, Min HY, Jeong LS, Lee HY. LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice. Biomol Ther (Seoul) 2020;28:250-8. [PMID: 32062956 DOI: 10.4062/biomolther.2019.162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 60 |
Schastlivtsev I, Lobastov K, Barinov V, Kanzafarova I. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study. Int Angiol 2020;39:361-71. [PMID: 32348101 DOI: 10.23736/S0392-9590.20.04356-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Mitsui S, Oe Y, Sekimoto A, Sato E, Hashizume Y, Yamakage S, Kumakura S, Sato H, Ito S, Takahashi N. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease. Am J Physiol Renal Physiol 2020;318:F1067-73. [PMID: 32200667 DOI: 10.1152/ajprenal.00595.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 62 |
Zuo P, Zhu Y, Li Y, Zuo Z, Sheng Z, Yan G, Ma G. Protease-activated receptor 2 deficiency in hematopoietic lineage protects against myocardial infarction through attenuated inflammatory response and fibrosis. Biochem Biophys Res Commun 2020;526:253-60. [PMID: 32204916 DOI: 10.1016/j.bbrc.2020.03.077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 63 |
Hassler SN, Kume M, Mwirigi JM, Ahmad A, Shiers S, Wangzhou A, Ray PR, Belugin SN, Naik DK, Burton MD, Vagner J, Boitano S, Akopian AN, Dussor G, Price TJ. The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain.. [DOI: 10.1101/2020.01.31.928663] [Reference Citation Analysis]
|
| 64 |
Kempuraj D, Selvakumar GP, Thangavel R, Ahmed ME, Zaheer S, Kumar KK, Yelam A, Kaur H, Dubova I, Raikwar SP, Iyer SS, Zaheer A. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation. J Alzheimers Dis 2018;66:1117-29. [PMID: 30372685 DOI: 10.3233/JAD-180786] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 65 |
Paraboschi EM, Khera AV, Merlini PA, Gigante L, Peyvandi F, Chaffin M, Menegatti M, Busti F, Girelli D, Martinelli N, Olivieri O, Kathiresan S, Ardissino D, Asselta R, Duga S. Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease. Haematologica 2020;105:e365-9. [PMID: 31699787 DOI: 10.3324/haematol.2019.237750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 66 |
Wang M, Ma Y, Zhang T, Gao L, Zhang S, Chen Q. Proteinase‑activated receptor 2 deficiency is a protective factor against cardiomyocyte apoptosis during myocardial ischemia/reperfusion injury. Mol Med Rep 2019;20:3764-72. [PMID: 31485622 DOI: 10.3892/mmr.2019.10618] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 67 |
Lephart ED. Equol’s efficacy is greater than astaxanthin for antioxidants, extracellular matrix integrity & breakdown, growth factors and inflammatory biomarkers via human skin gene expression analysis. Journal of Functional Foods 2019;59:380-93. [DOI: 10.1016/j.jff.2019.03.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 68 |
Pham PT, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Shimabukuro M, Sata M. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice. Sci Rep 2019;9:11206. [PMID: 31371788 DOI: 10.1038/s41598-019-47474-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 69 |
Ma FY, Han Y, Ozols E, Chew P, Vesey DA, Gobe GC, Morais C, Lohman RJ, Suen JY, Johnson DW, Fairlie DP, Nikolic-Paterson DJ. Protease-activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney. Nephrology (Carlton) 2019;24:983-91. [PMID: 31314137 DOI: 10.1111/nep.13635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 70 |
Méndez-Enríquez E, Hallgren J. Mast Cells and Their Progenitors in Allergic Asthma. Front Immunol 2019;10:821. [PMID: 31191511 DOI: 10.3389/fimmu.2019.00821] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 71 |
Tamura Y, Ohta H, Kagawa Y, Osuga T, Morishita K, Sasaki N, Takiguchi M. Plasma amino acid profiles in dogs with inflammatory bowel disease. J Vet Intern Med 2019;33:1602-7. [PMID: 31111561 DOI: 10.1111/jvim.15525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 72 |
Henehan M, De Benedetto A. Update on protease‐activated receptor 2 in cutaneous barrier, differentiation, tumorigenesis and pigmentation, and its role in related dermatologic diseases. Exp Dermatol 2019;28:877-85. [DOI: 10.1111/exd.13936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 73 |
Kim DH, Lee B, Lee J, Kim ME, Lee JS, Chung JH, Yu BP, Dong HH, Chung HY. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice. Redox Biol 2019;24:101184. [PMID: 30974318 DOI: 10.1016/j.redox.2019.101184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 74 |
Han Y, Tian L, Ma F, Tesch G, Vesey DA, Gobe GC, Lohman RJ, Morais C, Suen JY, Fairlie DP, Nikolic-Paterson DJ. Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis. Clin Exp Pharmacol Physiol 2019;46:456-64. [PMID: 30811624 DOI: 10.1111/1440-1681.13077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 75 |
Conway GD, Buzza MS, Martin EW, Duru N, Johnson TA, Peroutka RJ, Pawar NR, Antalis TM. PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4. J Mol Med (Berl) 2019;97:691-709. [PMID: 30911775 DOI: 10.1007/s00109-019-01763-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 76 |
Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, Rolland C, Meisel M, Murray JA, Yu XB, Alaedini A, Coombes BK, Bercik P, Southward CM, Ruf W, Jabri B, Chirdo FG, Casqueiro J, Surette MG, Vergnolle N, Verdu EF. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun 2019;10:1198. [PMID: 30867416 DOI: 10.1038/s41467-019-09037-9] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 77 |
Oe Y, Fushima T, Sato E, Sekimoto A, Kisu K, Sato H, Sugawara J, Ito S, Takahashi N. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury. Sci Rep 2019;9:2986. [PMID: 30814628 DOI: 10.1038/s41598-019-39914-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 78 |
Watanabe M, Oe Y, Sato E, Sekimoto A, Sato H, Ito S, Takahashi N. Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 2019;316:F654-9. [PMID: 30672316 DOI: 10.1152/ajprenal.00489.2018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 79 |
Benelhaj NE, Maraveyas A, Featherby S, Collier MEW, Johnson MJ, Ettelaie C. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex. Thromb Res 2019;175:13-20. [PMID: 30677622 DOI: 10.1016/j.thromres.2019.01.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 80 |
Pawar NR, Buzza MS, Antalis TM. Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression. Cancer Res 2019;79:301-10. [PMID: 30610085 DOI: 10.1158/0008-5472.CAN-18-1745] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 81 |
Lobastov K, Schastlivtsev I, Barinov V. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial. Adv Ther 2019;36:72-85. [PMID: 30539384 DOI: 10.1007/s12325-018-0849-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 82 |
Chen L, Gao B, Zhang Y, Lu H, Li X, Pan L, Yin L, Zhi X. PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway. J Cell Biochem 2019;120:9799-809. [PMID: 30552714 DOI: 10.1002/jcb.28260] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 83 |
Kennedy AJ, Ballante F, Johansson JR, Milligan G, Sundström L, Nordqvist A, Carlsson J. Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling. ACS Pharmacol Transl Sci 2018;1:119-33. [PMID: 32219208 DOI: 10.1021/acsptsci.8b00019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 84 |
Chimenti MS, Sunzini F, Fiorucci L, Botti E, Fonti GL, Conigliaro P, Triggianese P, Costa L, Caso F, Giunta A, Esposito M, Bianchi L, Santucci R, Perricone R. Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress. Front Immunol 2018;9:2363. [PMID: 30429845 DOI: 10.3389/fimmu.2018.02363] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 85 |
Posthuma JJ, Posma JJN, Schep G, Bender MMH, van Oerle R, van der Wal AC, Ten Cate H, Spronk HMH. Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes. J Vasc Surg 2019;69:1243-50. [PMID: 30314721 DOI: 10.1016/j.jvs.2018.05.220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 86 |
Wold EA, Chen J, Cunningham KA, Zhou J. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. J Med Chem 2019;62:88-127. [PMID: 30106578 DOI: 10.1021/acs.jmedchem.8b00875] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 87 |
D'alessandro E, Posma J, Spronk H, ten Cate H. Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope. Thrombosis Research 2018;168:130-7. [DOI: 10.1016/j.thromres.2018.06.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 88 |
Cho A, McKelvey KJ, Lee A, Hudson AL. The intertwined fates of inflammation and coagulation in glioma. Mamm Genome 2018;29:806-16. [PMID: 30062485 DOI: 10.1007/s00335-018-9761-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 89 |
Pryzdial ELG, Lee FMH, Lin BH, Carter RLR, Tegegn TZ, Belletrutti MJ. Blood coagulation dissected. Transfus Apher Sci 2018;57:449-57. [PMID: 30049564 DOI: 10.1016/j.transci.2018.07.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 90 |
Nadeau P, Henehan M, De Benedetto A. Activation of protease-activated receptor 2 leads to impairment of keratinocyte tight junction integrity. Journal of Allergy and Clinical Immunology 2018;142:281-284.e7. [DOI: 10.1016/j.jaci.2018.01.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 91 |
Aminian A, Noorbakhsh F, Department of Pharmacology, Arak University of Medical Sciences, Arak, Iran, Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran. Proteinase-Activated Receptors in The Nervous System: Physiological and Pathological Aspects. Shefaye Khatam 2018;6:69-78. [DOI: 10.29252/shefa.6.3.69] [Reference Citation Analysis]
|
| 92 |
Kempuraj D, Thangavel R, Selvakumar GP, Ahmed ME, Zaheer S, Raikwar SP, Zahoor H, Saeed D, Dubova I, Giler G, Herr S, Iyer SS, Zaheer A. Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB. Mol Neurobiol 2019;56:1681-93. [PMID: 29916143 DOI: 10.1007/s12035-018-1177-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 93 |
Zaidi AU, Heeney MM. A Scientific Renaissance: Novel Drugs in Sickle Cell Disease. Pediatr Clin North Am 2018;65:445-64. [PMID: 29803276 DOI: 10.1016/j.pcl.2018.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 94 |
Lee SH, Hao E, Scharp D, Levine F. Insulin acts as a repressive factor to inhibit the ability of PAR2 to induce islet cell transdifferentiation. Islets 2018;:1-12. [PMID: 29723131 DOI: 10.1080/19382014.2018.1472839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 95 |
Gandhi DM, Majewski MW, Rosas R Jr, Kentala K, Foster TJ, Greve E, Dockendorff C. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells. Bioorg Med Chem 2018;26:2514-29. [PMID: 29685684 DOI: 10.1016/j.bmc.2018.04.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
Faes C, Sparkenbaugh EM, Pawlinski R, Connes P. Hypercoagulable state in sickle cell disease. CH 2018;68:301-18. [DOI: 10.3233/ch-189013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 97 |
Teufelberger AR, Nordengrün M, Braun H, Maes T, De Grove K, Holtappels G, O'brien C, Provoost S, Hammad H, Gonçalves A, Beyaert R, Declercq W, Vandenabeele P, Krysko DV, Bröker BM, Bachert C, Krysko O. The IL-33/ST2 axis is crucial in type 2 airway responses induced by Staphylococcus aureus –derived serine protease–like protein D. Journal of Allergy and Clinical Immunology 2018;141:549-559.e7. [DOI: 10.1016/j.jaci.2017.05.004] [Cited by in Crossref: 81] [Cited by in F6Publishing: 71] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 98 |
Pryzdial ELG. Maestro tissue factor reaches new hEIGHT. Blood 2017;130:1604-5. [PMID: 28983017 DOI: 10.1182/blood-2017-08-798520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 99 |
Jiang Y, Yau MK, Lim J, Wu KC, Xu W, Suen JY, Fairlie DP. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells. J Pharmacol Exp Ther 2018;364:246-57. [PMID: 29263243 DOI: 10.1124/jpet.117.245027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 100 |
Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Shimabukuro M, Sata M. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury. Eur J Pharmacol 2018;820:222-8. [PMID: 29269019 DOI: 10.1016/j.ejphar.2017.12.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 101 |
White MJV, Chinea LE, Pilling D, Gomer RH. Protease activated-receptor 2 is necessary for neutrophil chemorepulsion induced by trypsin, tryptase, or dipeptidyl peptidase IV. J Leukoc Biol 2018;103:119-28. [PMID: 29345066 DOI: 10.1002/JLB.3A0717-308R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 102 |
Chao HH, Chen PY, Hao WR, Chiang WP, Cheng TH, Loh SH, Leung YM, Liu JC, Chen JJ, Sung LC. Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells. J Biomed Sci 2017;24:85. [PMID: 29141644 DOI: 10.1186/s12929-017-0393-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 103 |
Francis N, Every AL, Ayodele BA, Pike RN, Mackie EJ, Pagel CN. A T cell-specific knockout reveals an important role for protease-activated receptor 2 in lymphocyte development. The International Journal of Biochemistry & Cell Biology 2017;92:95-103. [DOI: 10.1016/j.biocel.2017.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 104 |
De Luca C, Virtuoso A, Maggio N, Papa M. Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases. Int J Mol Sci 2017;18:E2128. [PMID: 29023416 DOI: 10.3390/ijms18102128] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 105 |
Matsuda K, Okamoto N, Kondo M, Arkwright PD, Karasawa K, Ishizaka S, Yokota S, Matsuda A, Jung K, Oida K, Amagai Y, Jang H, Noda E, Kakinuma R, Yasui K, Kaku U, Mori Y, Onai N, Ohteki T, Tanaka A, Matsuda H. Mast cell hyperactivity underpins the development of oxygen-induced retinopathy. J Clin Invest 2017;127:3987-4000. [PMID: 28990934 DOI: 10.1172/JCI89893] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 106 |
Kempuraj D, Selvakumar GP, Zaheer S, Thangavel R, Ahmed ME, Raikwar S, Govindarajan R, Iyer S, Zaheer A. Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson's Disease. J Neuroimmune Pharmacol 2018;13:100-12. [PMID: 28952015 DOI: 10.1007/s11481-017-9766-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 107 |
Liu Y, Wu Z, Nakanishi Y, Ni J, Hayashi Y, Takayama F, Zhou Y, Kadowaki T, Nakanishi H. Infection of microglia with Porphyromonas gingivalis promotes cell migration and an inflammatory response through the gingipain-mediated activation of protease-activated receptor-2 in mice. Sci Rep 2017;7:11759. [PMID: 28924232 DOI: 10.1038/s41598-017-12173-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 108 |
Zuo P, Zuo Z, Zheng Y, Wang X, Zhou Q, Chen L, Ma G. Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice. Front Pharmacol 2017;8:647. [PMID: 28959204 DOI: 10.3389/fphar.2017.00647] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 109 |
McMahon DB, Workman AD, Kohanski MA, Carey RM, Freund JR, Hariri BM, Chen B, Doghramji LJ, Adappa ND, Palmer JN, Kennedy DW, Lee RJ. Protease-activated receptor 2 activates airway apical membrane chloride permeability and increases ciliary beating. FASEB J. 2018;32:155-167. [PMID: 28874459 DOI: 10.1096/fj.201700114rrr] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 110 |
Du C, Zhang T, Xiao X, Shi Y, Duan H, Ren Y. Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway. Biochem J 2017;474:2733-47. [PMID: 28694352 DOI: 10.1042/BCJ20170272] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 111 |
Alvarez M, Moura G, Machado M, Viana G, de Souza Costa C, Tjäderhane L, Nader H, Tersariol I, Nascimento F. PAR-1 and PAR-2 Expression Is Enhanced in Inflamed Odontoblast Cells. J Dent Res 2017;96:1518-25. [DOI: 10.1177/0022034517719415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 112 |
Wu J, Liu TT, Zhou YM, Qiu CY, Ren P, Jiao M, Hu WP. Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception. J Neuroinflammation 2017;14:150. [PMID: 28754162 DOI: 10.1186/s12974-017-0916-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 113 |
Hutchings CJ, Koglin M, Olson WC, Marshall FH. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov. 2017;16:787-810. [PMID: 28706220 DOI: 10.1038/nrd.2017.91] [Cited by in Crossref: 92] [Cited by in F6Publishing: 100] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 114 |
Nijs J, Loggia ML, Polli A, Moens M, Huysmans E, Goudman L, Meeus M, Vanderweeën L, Ickmans K, Clauw D. Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients? Expert Opinion on Therapeutic Targets 2017;21:817-26. [DOI: 10.1080/14728222.2017.1353603] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 115 |
Zhang L, Song J, Bai T, Qian W, Hou XH. Stress induces more serious barrier dysfunction in follicle-associated epithelium than villus epithelium involving mast cells and protease-activated receptor-2. Sci Rep 2017;7:4950. [PMID: 28694438 DOI: 10.1038/s41598-017-05064-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 116 |
Wilkinson DJ, Wang H, Habgood A, Lamb HK, Thompson P, Hawkins AR, Désilets A, Leduc R, Steinmetzer T, Hammami M, Lee MS, Craik CS, Watson S, Lin H, Milner JM, Rowan AD. Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms. Arthritis Rheumatol 2017;69:1601-11. [PMID: 28464560 DOI: 10.1002/art.40133] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 117 |
Sparkenbaugh E, Pawlinski R. Prothrombotic aspects of sickle cell disease. J Thromb Haemost 2017;15:1307-16. [DOI: 10.1111/jth.13717] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 118 |
Lee YJ, Kim SJ, Kwon KW, Lee WM, Im WJ, Sohn UD. Inhibitory effect of FSLLRY-NH2 on inflammatory responses induced by hydrogen peroxide in HepG2 cells. Arch Pharm Res 2017;40:854-63. [PMID: 28643288 DOI: 10.1007/s12272-017-0927-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 119 |
Jiang Y, Yau MK, Kok WM, Lim J, Wu KC, Liu L, Hill TA, Suen JY, Fairlie DP. Biased Signaling by Agonists of Protease Activated Receptor 2. ACS Chem Biol 2017;12:1217-26. [PMID: 28169521 DOI: 10.1021/acschembio.6b01088] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 120 |
Randhawa PK, Jaggi AS. A Review on Potential Involvement of TRPV 1 Channels in Ischemia–Reperfusion Injury. J Cardiovasc Pharmacol Ther 2018;23:38-45. [DOI: 10.1177/1074248417707050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 121 |
Koizume S, Miyagi Y. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply. Int J Mol Sci 2017;18:E809. [PMID: 28417928 DOI: 10.3390/ijms18040809] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 122 |
Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, Lambeir AM, De Meester I, De Man JG, De Winter BY. Regulation of intestinal permeability: The role of proteases. World J Gastroenterol 2017; 23(12): 2106-2123 [PMID: 28405139 DOI: 10.3748/wjg.v23.i12.2106] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 106] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 123 |
Shavit-Stein E, Artan-Furman A, Feingold E, Ben Shimon M, Itzekson-Hayosh Z, Chapman J, Vlachos A, Maggio N. Protease Activated Receptor 2 (PAR2) Induces Long-Term Depression in the Hippocampus through Transient Receptor Potential Vanilloid 4 (TRPV4). Front Mol Neurosci 2017;10:42. [PMID: 28303089 DOI: 10.3389/fnmol.2017.00042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 124 |
Grabs V, Kersten A, Haller B, Braun S, Nieman DC, Halle M, Scherr J. Rutoside and Hydrolytic Enzymes Do Not Attenuate Marathon-Induced Inflammation. Medicine & Science in Sports & Exercise 2017;49:387-95. [DOI: 10.1249/mss.0000000000001116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Pryzdial ELG, Lin BH, Sutherland MR. Virus–Platelet Associations. Platelets in Thrombotic and Non-Thrombotic Disorders 2017. [DOI: 10.1007/978-3-319-47462-5_72] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 126 |
Tanabe LM, List K. The role of type II transmembrane serine protease-mediated signaling in cancer. FEBS J 2017;284:1421-36. [PMID: 27870503 DOI: 10.1111/febs.13971] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 127 |
Hayashi S, Oe Y, Fushima T, Sato E, Sato H, Ito S, Takahashi N. Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice. Biochem Biophys Res Commun 2017;483:547-52. [PMID: 28025140 DOI: 10.1016/j.bbrc.2016.12.108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 128 |
Andersen HH. Protease-Activated Receptor-2: A Multifaceted Molecular Transducer in the Human Skin. Ann Dermatol 2016;28:771-2. [PMID: 27904281 DOI: 10.5021/ad.2016.28.6.771] [Reference Citation Analysis]
|
| 129 |
Lucena F, Foletto V, Mascarin LZ, Tonussi CR. Analgesic and anti-edematogenic effects of oral trypsin were abolished after subdiaphragmatic vagotomy and spinal monoaminergic inhibition in rats. Life Sci 2016;166:60-5. [PMID: 27729269 DOI: 10.1016/j.lfs.2016.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 130 |
Piran R, Lee SH, Kuss P, Hao E, Newlin R, Millán JL, Levine F. PAR2 regulates regeneration, transdifferentiation, and death. Cell Death Dis 2016;7:e2452. [PMID: 27809303 DOI: 10.1038/cddis.2016.357] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 131 |
Mrozkova P, Spicarova D, Palecek J. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors. PLoS One 2016;11:e0163991. [PMID: 27755539 DOI: 10.1371/journal.pone.0163991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 132 |
Cho N, Seo S, Kim D, Shin J, Ju J, Seong J, Seo SH, Lee I, Lee K, Kim YK, No KT, Pae AN. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist. J Comput Aided Mol Des 2016;30:625-37. [DOI: 10.1007/s10822-016-9937-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 133 |
Kallikrein in the Interstitial Space. Protein Science 2016. [DOI: 10.1201/9781315374307-7] [Reference Citation Analysis]
|
| 134 |
Stahn S, Thelen L, Albrecht IM, Bitzer J, Henkel T, Teusch NE. Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells. Pharmacol Res Perspect 2016;4:e00230. [PMID: 28116092 DOI: 10.1002/prp2.230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 135 |
Oe Y, Hayashi S, Fushima T, Sato E, Kisu K, Sato H, Ito S, Takahashi N. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy. Arterioscler Thromb Vasc Biol 2016;36:1525-33. [PMID: 27283743 DOI: 10.1161/ATVBAHA.116.307883] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 136 |
Chang AY, Mann TS, McFawn PK, Han L, Dong X, Henry PJ. Investigating the role of MRGPRC11 and capsaicin-sensitive afferent nerves in the anti-influenza effects exerted by SLIGRL-amide in murine airways. Respir Res 2016;17:62. [PMID: 27215903 DOI: 10.1186/s12931-016-0378-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 137 |
Hirai C, Sugimura M, Makino S, Takeda S. Chymotrypsin Enhances Soluble Fms-Like Tyrosine Kinase 1 Production Through Protease-Activated Receptor 2 in Placenta-Derived Immortalized Human Trophoblast Cells. Reprod Sci 2016;23:1542-50. [PMID: 27140908 DOI: 10.1177/1933719116646203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 138 |
Mrozkova P, Palecek J, Spicarova D. The role of protease-activated receptor type 2 in nociceptive signaling and pain. Physiol Res 2016;65:357-67. [PMID: 27070742 DOI: 10.33549/physiolres.933269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 139 |
Tada H, Matsuyama T, Nishioka T, Hagiwara M, Kiyoura Y, Shimauchi H, Matsushita K. Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells. PLoS One 2016;11:e0152794. [PMID: 27058037 DOI: 10.1371/journal.pone.0152794] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 140 |
Yau MK, Lim J, Liu L, Fairlie DP. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert Opin Ther Pat 2016;26:471-83. [PMID: 26936077 DOI: 10.1517/13543776.2016.1154540] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 141 |
Gur-Cohen S, Kollet O, Graf C, Esmon CT, Ruf W, Lapidot T. Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling. Ann N Y Acad Sci 2016;1370:65-81. [PMID: 26928241 DOI: 10.1111/nyas.13013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 142 |
Hehir DA, Easley RB, Byrnes J. Noncardiac Challenges in the Cardiac ICU. World J Pediatr Congenit Heart Surg 2016;7:199-209. [DOI: 10.1177/2150135115615847] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 143 |
Bonato L, Quinelato V, Pinheiro A, Amaral M, de Souza F, Lobo J, Aguiar D, Augusto L, Vieira A, Salles J, Cossich V, Guimarães J, de Gouvêa C, Granjeiro J, Casado P. ESRRB polymorphisms are associated with comorbidity of temporomandibular disorders and rotator cuff disease. International Journal of Oral and Maxillofacial Surgery 2016;45:323-31. [DOI: 10.1016/j.ijom.2015.10.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 144 |
Elistratova IV, Morozov SG, Zakharova IA. Expression proteaseinhibitors receptor PAR-2 on neutrophils peripheral blood of patients with atopic dermatitis and their relation with heat shock proteins HSP90. Russ J Skin & Ven Dis 2016;19:53-58. [DOI: 10.18821/1560-9588-2016-19-1-53-58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 145 |
Johnson JJ, Miller DL, Jiang R, Liu Y, Shi Z, Tarwater L, Williams R, Balsara R, Sauter ER, Stack MS. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma. J Biol Chem 2016;291:6936-45. [PMID: 26839311 DOI: 10.1074/jbc.M115.692640] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 146 |
Yau M, Liu L, Lim J, Lohman R, Cotterell AJ, Suen JY, Vesey DA, Reid RC, Fairlie DP. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity. Bioorganic & Medicinal Chemistry Letters 2016;26:986-91. [DOI: 10.1016/j.bmcl.2015.12.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 147 |
Sparkenbaugh EM, Chantrathammachart P, Chandarajoti K, Mackman N, Key NS, Pawlinski R. Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease. Blood 2016;127:1371-3. [PMID: 26817955 DOI: 10.1182/blood-2015-11-681114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 148 |
Jin M, Yang HW, Tao AL, Wei JF. Evolution of the protease-activated receptor family in vertebrates. Int J Mol Med 2016;37:593-602. [PMID: 26820116 DOI: 10.3892/ijmm.2016.2464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 149 |
Yau MK, Suen JY, Xu W, Lim J, Liu L, Adams MN, He Y, Hooper JD, Reid RC, Fairlie DP. Potent Small Agonists of Protease Activated Receptor 2. ACS Med Chem Lett 2016;7:105-10. [PMID: 26819675 DOI: 10.1021/acsmedchemlett.5b00429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 150 |
Bradshaw R, Lundblad R. Kallikrein. Encyclopedia of Cell Biology 2016. [DOI: 10.1016/b978-0-12-394447-4.10090-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 151 |
Brown L, Poudyal H, Panchal SK. Functional foods as potential therapeutic options for metabolic syndrome. Obes Rev 2015;16:914-41. [PMID: 26345360 DOI: 10.1111/obr.12313] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 13.9] [Reference Citation Analysis]
|
| 152 |
Wu L, Oshima T, Shan J, Sei H, Tomita T, Ohda Y, Fukui H, Watari J, Miwa H. PAR-2 activation enhances weak acid-induced ATP release through TRPV1 and ASIC sensitization in human esophageal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2015;309:G695-702. [PMID: 26294672 DOI: 10.1152/ajpgi.00162.2015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 153 |
Arumugam PI, Mullins ES, Shanmukhappa SK, Monia BP, Loberg A, Shaw MA, Rizvi T, Wansapura J, Degen JL, Malik P. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice. Blood 2015;126:1844-55. [PMID: 26286849 DOI: 10.1182/blood-2015-01-625707] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 154 |
Yu Y, Chen H, Su SB. Neuroinflammatory responses in diabetic retinopathy. J Neuroinflammation 2015;12:141. [PMID: 26245868 DOI: 10.1186/s12974-015-0368-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 155 |
Lin C, von der Thüsen J, Daalhuisen J, ten Brink M, Crestani B, van der Poll T, Borensztajn K, Spek CA. Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis. Mol Med 2015;21:576-83. [PMID: 26147947 DOI: 10.2119/molmed.2015.00094] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 156 |
Guenther F, Melzig MF. Protease-activated receptors and their biological role - focused on skin inflammation. J Pharm Pharmacol 2015;67:1623-33. [PMID: 26709036 DOI: 10.1111/jphp.12447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 157 |
Hurley MJ, Durrenberger PF, Gentleman SM, Walls AF, Dexter DT. Altered Expression of Brain Proteinase-Activated Receptor-2, Trypsin-2 and Serpin Proteinase Inhibitors in Parkinson's Disease. J Mol Neurosci 2015;57:48-62. [PMID: 25982926 DOI: 10.1007/s12031-015-0576-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 158 |
van den Boogaard FE, van 't Veer C, Roelofs JJ, Meijers JC, Schultz MJ, Broze GJ Jr, van der Poll T. Endogenous tissue factor pathway inhibitor has a limited effect on host defence in murine pneumococcal pneumonia. Thromb Haemost 2015;114:115-22. [PMID: 25832548 DOI: 10.1160/TH14-12-1053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 159 |
Hara T, Fukuda D, Tanaka K, Higashikuni Y, Hirata Y, Nishimoto S, Yagi S, Yamada H, Soeki T, Wakatsuki T, Shimabukuro M, Sata M. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Atherosclerosis 2015;242:639-46. [PMID: 25817329 DOI: 10.1016/j.atherosclerosis.2015.03.023] [Cited by in Crossref: 107] [Cited by in F6Publishing: 93] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 160 |
Ruf W, Samad F. Tissue factor pathways linking obesity and inflammation. Hamostaseologie 2015;35:279-83. [PMID: 25623940 DOI: 10.5482/HAMO-14-11-0068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 161 |
Reinhardt C, Manukyan D, Ruf W. The Role of Coagulation Factor Signaling in Angiogenesis and Vascular Remodeling. Endothelial Signaling in Development and Disease 2015. [DOI: 10.1007/978-1-4939-2907-8_10] [Reference Citation Analysis]
|
| 162 |
Sugimura M. Is thrombin a “toxin” in the pathogenesis of preeclampsia? Hypertens Res Pregnancy 2015;3:13-8. [DOI: 10.14390/jsshp.3.13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 163 |
Tada H, Shimauchi H, Takada H, Matsushita K. Possible Roles of IL-33 in Periodontal Diseases: Porphyromonas gingivalis Induced IL-33 in Human Gingival Epithelial Cells. Interface Oral Health Science 2014 2015. [DOI: 10.1007/978-4-431-55192-8_25] [Reference Citation Analysis]
|
| 164 |
Ohashi Y, Miyamoto Y, Iekushi K. Clinical development of novel oral anticoagulant (NOAC), Rivaroxaban. Nihon Kessen Shiketsu Gakkaishi 2015;26:385-395. [DOI: 10.2491/jjsth.26.385] [Reference Citation Analysis]
|
| 165 |
Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, Meeusen R. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target. Expert Opin Ther Targets. 2014; Dec 18. [Epub ahead of print]. [PMID: 25519921 DOI: 10.1517/14728222.2014.994506] [Cited by in Crossref: 96] [Cited by in F6Publishing: 104] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 166 |
Sitaras N, Rivera JC, Noueihed B, Bien-Aimé M, Zaniolo K, Omri S, Hamel D, Zhu T, Hardy P, Sapieha P, Joyal JS, Chemtob S. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2. Am J Pathol 2015;185:581-95. [PMID: 25478809 DOI: 10.1016/j.ajpath.2014.10.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 167 |
Pryzdial EL, Sutherland MR, Ruf W. The procoagulant envelope virus surface: contribution to enhanced infection. Thromb Res 2014;133 Suppl 1:S15-7. [PMID: 24759132 DOI: 10.1016/j.thromres.2014.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 168 |
Pfeiler S, Massberg S, Engelmann B. Biological basis and pathological relevance of microvascular thrombosis. Thromb Res 2014;133 Suppl 1:S35-7. [PMID: 24759139 DOI: 10.1016/j.thromres.2014.03.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 169 |
Saffarzadeh M, Preissner KT. Moonlighting proteins dictate the crosstalk between thrombosis and innate immunity. J Thromb Haemost 2014;12:2070-3. [PMID: 25315144 DOI: 10.1111/jth.12754] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 170 |
Shi K, Queiroz KC, Roelofs JJ, van Noesel CJ, Richel DJ, Spek CA. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model: PAR-2 reduces metastasis in pancreatic cancer model. J Pathol 2014;234:398-409. [DOI: 10.1002/path.4411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 171 |
Lim MX, Png CW, Tay CY, Teo JD, Jiao H, Lehming N, Tan KS, Zhang Y. Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection. Infect Immun 2014;82:4789-801. [PMID: 25156742 DOI: 10.1128/IAI.02279-14] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 172 |
Kakarala KK, Jamil K, Devaraji V. Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) - a promising target for breast cancer. J Mol Graph Model 2014;53:179-99. [PMID: 25173751 DOI: 10.1016/j.jmgm.2014.07.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 173 |
Keller MF, Reiner AP, Okada Y, van Rooij FJ, Johnson AD, Chen MH, Smith AV, Morris AP, Tanaka T, Ferrucci L, Zonderman AB, Lettre G, Harris T, Garcia M, Bandinelli S, Qayyum R, Yanek LR, Becker DM, Becker LC, Kooperberg C, Keating B, Reis J, Tang H, Boerwinkle E, Kamatani Y, Matsuda K, Kamatani N, Nakamura Y, Kubo M, Liu S, Dehghan A, Felix JF, Hofman A, Uitterlinden AG, van Duijn CM, Franco OH, Longo DL, Singleton AB, Psaty BM, Evans MK, Cupples LA, Rotter JI, O'Donnell CJ, Takahashi A, Wilson JG, Ganesh SK, Nalls MA; CHARGE Hematology., COGENT., BioBank Japan Project (RIKEN) Working Groups. Trans-ethnic meta-analysis of white blood cell phenotypes. Hum Mol Genet 2014;23:6944-60. [PMID: 25096241 DOI: 10.1093/hmg/ddu401] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 174 |
Weithauser A, Rauch U. Role of protease-activated receptors for the innate immune response of the heart. Trends Cardiovasc Med. 2014;24:249-255. [PMID: 25066486 DOI: 10.1016/j.tcm.2014.06.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 175 |
Windschüttl S, Nettersheim D, Schlatt S, Huber A, Welter H, Schwarzer JU, Köhn FM, Schorle H, Mayerhofer A. Are testicular mast cells involved in the regulation of germ cells in man? Andrology 2014;2:615-22. [DOI: 10.1111/j.2047-2927.2014.00227.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 176 |
Alberelli MA, De Candia E. Functional role of protease activated receptors in vascular biology. Vascul Pharmacol. 2014;62:72-81. [PMID: 24924409 DOI: 10.1016/j.vph.2014.06.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 177 |
Görgens SW, Eckardt K, Elsen M, Tennagels N, Eckel J. Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance. Biochem J 2014;459:479-88. [PMID: 24512683 DOI: 10.1042/BJ20131151] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 178 |
Shi K, Queiroz KC, Stap J, Richel DJ, Spek CA. Protease-activated receptor-2 induces migration of pancreatic cancer cells in an extracellular ATP-dependent manner. J Thromb Haemost. 2013;11:1892-1902. [PMID: 23899344 DOI: 10.1111/jth.12361] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 179 |
Bao Y, Hou W, Liu R, Gao Y, Kong X, Yang L, Shi Z, Li W, Zheng H, Jiang S, Li C, Qin Y, Hua B. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain. Mol Pain 2014;10:28. [PMID: 24886294 DOI: 10.1186/1744-8069-10-28] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 180 |
Liu P, Sun L, Zhao X, Zhang P, Zhao X, Zhang J. PAR2-mediated epigenetic upregulation of α-synuclein contributes to the pathogenesis of Parkinson׳s disease. Brain Research 2014;1565:82-9. [DOI: 10.1016/j.brainres.2014.04.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 181 |
Hoppe CC. Inflammatory Mediators of Endothelial Injury in Sickle Cell Disease. Hematology/Oncology Clinics of North America 2014;28:265-86. [DOI: 10.1016/j.hoc.2013.11.006] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 182 |
Park MK, Cho MK, Kang SA, Park HK, Kim DH, Yu HS. Acanthamoeba protease activity promotes allergic airway inflammation via protease-activated receptor 2. PLoS One 2014;9:e92726. [PMID: 24658532 DOI: 10.1371/journal.pone.0092726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 183 |
Ibelli AM, Kim TK, Hill CC, Lewis LA, Bakshi M, Miller S, Porter L, Mulenga A. A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting. Int J Parasitol 2014;44:369-79. [PMID: 24583183 DOI: 10.1016/j.ijpara.2014.01.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 184 |
Sales KU, Friis S, Konkel JE, Godiksen S, Hatakeyama M, Hansen KK, Rogatto SR, Szabo R, Vogel LK, Chen W, Gutkind JS, Bugge TH. Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis. Oncogene 2015;34:346-56. [PMID: 24469043 DOI: 10.1038/onc.2013.563] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 185 |
Sparkenbaugh EM, Chantrathammachart P, Mickelson J, van Ryn J, Hebbel RP, Monroe DM, Mackman N, Key NS, Pawlinski R. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood 2014;123:1747-56. [PMID: 24449213 DOI: 10.1182/blood-2013-08-523936] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 186 |
Diepeveen ET, Roth O, Salzburger W. Immune-related functions of the Hivep gene family in East African cichlid fishes. G3 (Bethesda) 2013;3:2205-17. [PMID: 24142922 DOI: 10.1534/g3.113.008839] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 187 |
Heng BC, Aubel D, Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 2013;31:1676-94. [DOI: 10.1016/j.biotechadv.2013.08.017] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 188 |
Chung H, Ramachandran R, Hollenberg MD, Muruve DA. Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis. J Biol Chem 2013;288:37319-31. [PMID: 24253040 DOI: 10.1074/jbc.M113.492793] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 189 |
Gieseler F, Ungefroren H, Settmacher U, Hollenberg MD, Kaufmann R. Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact. Cell Commun Signal 2013;11:86. [PMID: 24215724 DOI: 10.1186/1478-811X-11-86] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 190 |
Nakayama M, Niki Y, Kawasaki T, Takeda Y, Ikegami H, Toyama Y, Miyamoto T. IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis. Sci Rep 2013;3:2960. [PMID: 24129891 DOI: 10.1038/srep02960] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 191 |
Samad F, Ruf W. Inflammation, obesity, and thrombosis. Blood 2013;122:3415-22. [PMID: 24092932 DOI: 10.1182/blood-2013-05-427708] [Cited by in Crossref: 231] [Cited by in F6Publishing: 243] [Article Influence: 23.1] [Reference Citation Analysis]
|
| 192 |
de Boer JD, Van't Veer C, Stroo I, van der Meer AJ, de Vos AF, van der Zee JS, Roelofs JJ, van der Poll T. Protease-activated receptor-2 deficient mice have reduced house dust mite-evoked allergic lung inflammation. Innate Immun 2014;20:618-25. [PMID: 24048772 DOI: 10.1177/1753425913503387] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 193 |
Li Q, Jie Y, Wang C, Zhang Y, Guo H, Pan Z. Tryptase compromises corneal epithelial barrier function: TRYPTASE AND CORNEAL BARRIER FUNCTION. Cell Biochem Funct 2014;32:183-7. [DOI: 10.1002/cbf.2991] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 194 |
White MJ, Glenn M, Gomer RH. Trypsin potentiates human fibrocyte differentiation. PLoS One 2013;8:e70795. [PMID: 23951012 DOI: 10.1371/journal.pone.0070795] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 195 |
Yau MK, Liu L, Fairlie DP. Toward drugs for protease-activated receptor 2 (PAR2). J Med Chem 2013;56:7477-97. [PMID: 23895492 DOI: 10.1021/jm400638v] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 196 |
Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112:1506-19. [PMID: 23704217 DOI: 10.1161/CIRCRESAHA.113.300512] [Cited by in Crossref: 207] [Cited by in F6Publishing: 218] [Article Influence: 20.7] [Reference Citation Analysis]
|
| 197 |
Cottrell GS. Roles of proteolysis in regulation of GPCR function. Br J Pharmacol 2013;168:576-90. [PMID: 23043558 DOI: 10.1111/j.1476-5381.2012.02234.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 198 |
Groschwitz KR, Wu D, Osterfeld H, Ahrens R, Hogan SP. Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2013;304:G479-89. [PMID: 23306080 DOI: 10.1152/ajpgi.00186.2012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 199 |
Li M, Zhu M, Zhu B, Wang Z. Tryptase disturbs endocytic allergen degradation in intestinal epithelial cells. Analytical Biochemistry 2013;434:54-9. [DOI: 10.1016/j.ab.2012.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 200 |
Morla L, Brideau G, Fila M, Crambert G, Cheval L, Houillier P, Ramakrishnan S, Imbert-Teboul M, Doucet A. Renal proteinase-activated receptor 2, a new actor in the control of blood pressure and plasma potassium level. J Biol Chem. 2013;288:10124-10131. [PMID: 23430254 DOI: 10.1074/jbc.m112.446393] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 201 |
Kida Y, Taira J, Yamamoto T, Higashimoto Y, Kuwano K. EprS, an autotransporter protein of Pseudomonas aeruginosa, possessing serine protease activity induces inflammatory responses through protease-activated receptors. Cell Microbiol. 2013;15:1168-1181. [PMID: 23311922 DOI: 10.1111/cmi.12106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 202 |
Flynn AN, Hoffman J, Tillu DV, Sherwood CL, Zhang Z, Patek R, Asiedu MN, Vagner J, Price TJ, Boitano S. Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering. FASEB J 2013;27:1498-510. [PMID: 23292071 DOI: 10.1096/fj.12-217323] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 203 |
Vesey DA, Suen JY, Seow V, Lohman RJ, Liu L, Gobe GC, Johnson DW, Fairlie DP. PAR2-induced inflammatory responses in human kidney tubular epithelial cells. Am J Physiol Renal Physiol 2013;304:F737-50. [PMID: 23283995 DOI: 10.1152/ajprenal.00540.2012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 204 |
Shan J, Oshima T, Chen X, Fukui H, Watari J, Miwa H. Trypsin impaired epithelial barrier function and induced IL-8 secretion through basolateral PAR-2: a lesson from a stratified squamous epithelial model. Am J Physiol Gastrointest Liver Physiol 2012;303:G1105-12. [PMID: 22997195 DOI: 10.1152/ajpgi.00220.2012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 205 |
Collin N, Assumpção TC, Mizurini DM, Gilmore DC, Dutra-Oliveira A, Kotsyfakis M, Sá-Nunes A, Teixeira C, Ribeiro JM, Monteiro RQ, Valenzuela JG, Francischetti IM. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo. Arterioscler Thromb Vasc Biol 2012;32:2185-98. [PMID: 22796577 DOI: 10.1161/ATVBAHA.112.253906] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 206 |
Chantrathammachart P, Mackman N, Sparkenbaugh E, Wang JG, Parise LV, Kirchhofer D, Key NS, Pawlinski R. Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood 2012;120:636-46. [PMID: 22661702 DOI: 10.1182/blood-2012-04-424143] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
|
